Corey McCann, Pear Therapeutics CEO
The digital health field continues to boom as SoftBank-backed startup hits unicorn status in SPAC reverse merger
Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.
At the intersection of medicine and cutting-edge technology …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.